Sort
21,453 grants matching “tuberculosis”
Clinical safety and pharmacokinetic studies of intravaginal rings releasing multiple antiretrovirals
$637,265Thomas J. Smith · Auritec Pharmaceuticals, Inc. · R44 · FY2016 · HD
Systems Biology, Bioinformatics, & Data Integration
$637,128Catherine Marie Stein · University Of Washington · U19 · FY2022 · AI
Identification of new inhibitors of essential functions in M. tuberculosis by high-throughput metabolic profiling
$636,812Michael Berney · Albert Einstein College Of Medicine · R01 · FY2024 · AI
Identification of new inhibitors of essential functions in M. tuberculosis by high-throughput metabolic profiling
$636,812Michael Berney · Albert Einstein College Of Medicine · R01 · FY2025 · AI
Role of CD8 T cells in immunity to tuberculosis
$636,762Zheng W Chen · University Of Illinois At Chicago · R01 · FY2007 · RR
Immune correlates of tuberculosis and non-tuberculosis infectious morbidity in Southern African HIV-exposed, uninfected infants.
$636,736Kathleen Powis · Massachusetts General Hospital · R01 · FY2020 · AI
Role of CD8 T cells in immunity to tuberculosis
$636,678Zheng W Chen · University Of Illinois At Chicago · R01 · FY2006 · RR
Improving Diagnostics and Neurocognitive Outcomes in HIV/AIDS-related Meningitis
$636,646David R Boulware · University Of Minnesota · R01 · FY2015 · NS
Improving Diagnostics and Neurocognitive Outcomes in HIV/AIDS-related Meningitis
$636,646David R Boulware · University Of Minnesota · R01 · FY2016 · NS
Improving Diagnostics and Neurocognitive Outcomes in HIV/AIDS-related Meningitis
$636,646David R Boulware · University Of Minnesota · R01 · FY2017 · NS
Project 4: Quantification and Biomarkers of Short-Term Pulmonary Effect p302-340
$636,571Carolyn Calfee · University Of California, San Francisco · P50 · FY2015 · CA
Sirtuins and Host Metabolism in TB Pathogenesis and Treatment
$636,398Hardy Kornfeld · Univ Of Massachusetts Med Sch Worcester · R01 · FY2022 · HL
Prevention and Treatment of Tuberculosis in the State of Oklahoma
$636,376Lauri Smithee · Oklahoma State Department Of Health · U52 · FY2013 · PS
Latent and Reactivation Tuberculosis
$636,326Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2006 · HL
The impact of alcohol consumption on TB treatment outcomes
$636,004Karen R Jacobson · Boston Medical Center · R01 · FY2017 · AI
ART Adherence: Observed Therapy and Enhanced Counseling
$635,987Kathy J Goggin · University Of Missouri Kansas City · R01 · FY2008 · MH
Host Response to TB and AIDS
$635,945New York University School Of Medicine · R01 · FY2002 · HL
Project 4: Quantification and Biomarkers of Short-Term Pulmonary Effect
$635,852Carolyn Calfee · University Of California, San Francisco · P50 · FY2017 · CA
Experimental Animal Models of TB: Chemotherapeutics and Imaging
$635,835Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Development Of New Chemotherapeutics For Tuberculosis
$635,835Clifton Barry · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
The roles of genetics, hormones, and gender in sexually dimorphic immune response
$635,560Timothy J. Triche · Van Andel Research Institute · R01 · FY2022 · AI
Longitudinal Study of HIV and Aging in Brazil
$635,549Jessica L Castilho · Vanderbilt University Medical Center · R01 · FY2025 · AG
Latent and Reactivation Tuberculosis
$635,416University Of Pittsburgh At Pittsburgh · R01 · FY2005 · HL
Clinical Interventional Studies of HIV Reservoirs
$635,273Frank Maldarelli · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Addressing HyperteNsion and Diabetes through Community-Engaged Systems in Puno, Peru (ANDES study)
$635,044Stella Maria Hartinger · Universidad Peruana Cayetano Heredia · UG3 · FY2021 · HL